Jupiter Life Line Hospitals Limited has announced an investor conference scheduled for February 25, 2026, organized by Kotak Institutional Equities. The healthcare company informed both the National Stock Exchange of India and BSE Limited about the upcoming meeting through a regulatory filing dated February 18, 2026.

Conference Details

The investor conference will be held in Mumbai with specific timing and organizational details outlined by the company.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 (6) read with Schedule III (Part A) (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company officials will be attending the conference to engage with analysts and institutional investors.

The company has clarified that discussions during the conference will be limited to publicly available documents. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions, ensuring compliance with regulatory guidelines.

Additional Information

Jupiter Life Line Hospitals Limited has noted that changes to the schedule may occur due to exigencies on the part of the host or company. The conference details will be made available on the company's website at www.jupiterhospital.com .

The regulatory filing was signed by Suma Upparatti, Company Secretary & Compliance Officer, ensuring proper authorization and compliance with disclosure requirements. This investor conference represents an opportunity for the company to engage with the investment community and provide updates on its operations and performance.

Jupiter life line hospital Limited has announced its participation in an upcoming investor conference, providing stakeholders with an opportunity to engage directly with company officials. The healthcare company filed the requisite disclosure with stock exchanges on February 4, 2026, in compliance with regulatory requirements.

Meeting Details and Schedule

The investor engagement is scheduled as part of the Nuvama Conference, with specific arrangements outlined for interested participants.

Regulatory Compliance and Information Sharing

The company has emphasized its commitment to regulatory compliance and transparent communication practices. Jupiter Life Line Hospitals Limited confirmed that all discussions during the investor interactions will be based exclusively on publicly available documents. The company explicitly stated that no unpublished price sensitive information (UPSI) will be discussed during these meetings, ensuring adherence to securities regulations.

Accessibility and Documentation

To maintain transparency, the company announced that details of the investor meeting will be made available on its official website at www.jupiterhospital.com . This ensures broader accessibility for stakeholders who may wish to review the information shared during the conference.

Operational Flexibility

The company has noted that the scheduled meeting details may be subject to changes due to operational exigencies on the part of either the host organization or the company itself. This provision allows for necessary adjustments while maintaining the commitment to investor engagement.

The disclosure was signed by Suma Upparatti, Company Secretary & Compliance Officer, demonstrating proper corporate governance protocols in the announcement of this investor relations activity.